| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |